Clinical Trial Transparency - Antidote to Weaker Off-Label-Promotion Rules?

The New England Journal of Medicine 371;1 July 3, 2014

Boston Univ. School of Law, Public Law Research Paper No. 14-77

4 Pages Posted: 9 Aug 2015 Last revised: 15 Aug 2015

Date Written: July 1, 2014

Abstract

Clinical trial transparency will improve the accuracy and reliability of biomedical science, while also reducing the burdens on both trial participants and sponsors.

Keywords: clinical trial transparency, biomedical science

JEL Classification: I12, I19, K32, K39

Suggested Citation

Outterson, Kevin, Clinical Trial Transparency - Antidote to Weaker Off-Label-Promotion Rules? (July 1, 2014). The New England Journal of Medicine 371;1 July 3, 2014, Boston Univ. School of Law, Public Law Research Paper No. 14-77, Available at SSRN: https://ssrn.com/abstract=2641135

Kevin Outterson (Contact Author)

Boston University School of Law ( email )

765 Commonwealth Avenue
Boston, MA 02215
United States

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
17
Abstract Views
509
PlumX Metrics